U.S. market Closed. Opens in 14 hours 29 minutes

APGE | Apogee Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-31
RevenueN/AN/A
Cost of RevenueN/AN/A
Gross ProfitN/AN/A
Operating Expenses93.00M30.73M
Selling, General & Admin24.58M2.94M
Research & Development68.42M27.79M
Other Operating ExpensesN/AN/A
Operating Income-93.00M-30.73M
Other Expenses / Income9.02M-9.06M
Before Tax Income-83.98M-39.78M
Income Tax ExpensesN/A-33.52K
Net Income-83.98M-39.78M
Interest ExpensesN/A9.15M
Basic Shares Outstanding25.01B50.67M
Diluted Shares Outstanding25.01B50.67M
EBITDA-83.98MN/A
EBITDA Margin0.00%0.00%
EBIT-83.98M-30.67M
EBIT Margin0.00%0.00%
Financial Year End2023-12-312022-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙